av/acrivon-therapeutics--big.svg

COM:ACRIVON

Acrivon

  • Stock

Last Close

6.44

22/11 21:00

Market Cap

221.08M

Beta: -

Volume Today

25.35K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
net income
-5.31M
-
-16.24M
206.13%
-31.17M
91.88%
-60.39M
93.76%
depreciation and amortization
13K
-
37K
184.62%
364K
883.78%
-2.79M
865.66%
deferred income tax
71K
-
255K
259.15%
stock based compensation
3K
-
497K
16,466.67%
2.19M
339.64%
11.62M
431.72%
change in working capital
317K
-
328K
3.47%
-1.53M
567.07%
3.61M
335.57%
accounts receivables
inventory
accounts payables
81K
-
798K
885.19%
-245K
130.70%
3.61M
1,573.06%
other working capital
236K
-
-470K
299.15%
-1.29M
173.83%
-3.61M
180.42%
other non cash items
2.10M
-
1.14M
45.50%
33K
97.12%
8.92M
26,918.18%
net cash provided by operating activities
-2.80M
-
-13.98M
398.82%
-30.12M
115.40%
-42.64M
41.58%
investments in property plant and equipment
-15K
-
-238K
1,486.67%
-2.17M
810.08%
-1.29M
40.54%
acquisitions net
purchases of investments
-150.18M
-
-56.53M
62.36%
sales maturities of investments
10.67M
-
108.53M
917.37%
other investing activites
net cash used for investing activites
-15K
-
-238K
1,486.67%
-141.68M
59,427.73%
50.72M
135.80%
debt repayment
-58K
-
common stock issued
2.83M
-
112.22M
3,864.01%
104.46M
6.92%
common stock repurchased
dividends paid
other financing activites
116K
-
-2.75M
-
-1.55M
43.47%
net cash used provided by financing activities
2.89M
-
112.22M
3,784.42%
101.71M
9.37%
-1.55M
101.53%
effect of forex changes on cash
net change in cash
71K
-
98.00M
137,929.58%
-70.08M
171.51%
6.52M
109.31%
cash at beginning of period
1.92M
-
1.99M
3.70%
99.99M
4,924.67%
29.91M
70.09%
cash at end of period
1.99M
-
99.99M
4,924.67%
29.91M
70.09%
36.43M
21.81%
operating cash flow
-2.80M
-
-13.98M
398.82%
-30.12M
115.40%
-42.64M
41.58%
capital expenditure
-15K
-
-238K
1,486.67%
-2.17M
810.08%
-1.29M
40.54%
free cash flow
-2.82M
-
-14.22M
404.61%
-32.28M
127.03%
-43.93M
36.07%

All numbers in (except ratios and percentages)